Sunday, January 30, 2022
During #COVID19Pandemic "Protective Measures Important" along with #vaccination says M.A.Aleem #Neurologist #Trichy #Tamilnadu #India in the Readers Mail Column of #Trichy The Hindu @the_hindu on 31.01.2022Reader’s Mail https://www.thehindu.com/todays-paper/tp-national/tp-tamilnadu/readers-mail/article38351716.ece
Wednesday, January 26, 2022
Tuesday, January 25, 2022
Monday, January 24, 2022
Wednesday, January 19, 2022
Tuesday, January 18, 2022
Re:Covid-19: This is a gamble and not a planBMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o71 (Published 13 January 2022)Cite this as: BMJ 2022;376:o71
Editor's Choice
Covid-19: This is a gamble and not a plan
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o71 (Published 13 January 2022)
Cite this as: BMJ 2022;376:o71
Re: Covid-19: This is a gamble and not a plan
Dear Editor
Symptoms of Omicron are “very, very mild” compared with those of the Delta variant.
Unlike in other variants, patients with Omicron infection have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.
The following are symptoms of Omicron:
A. Cough, cold and fever are common symptoms of Covid, be it Omicron or Delta.
Pulmonary alveolar involvement by Delta induces a dry cough, which is common in Delta infection.
Tracheo bronchitis of Omicron causes secretions not seen with Delta. So a Sore throat with mild secretions is seen with Omicron infection.
Often patients do not expectorate the secretions but may just swallow.
B. Sore throat is a very common symptom of Omicron, not so much of Delta, but it may happen sometimes.
C. Headache, tiredness, body pain are apparently more prominent symptoms of Omicron infection than of Delta.
D. Breathing problems are a very rare symptom of Omicron but very common in Delta.
E. General upper respiratory symptoms (cold, cough, sore throat) plus prominent gastrointestinal symptoms (nausea, vomiting, diarrhoea) along with fever, tiredness muscle pain in the lower back and lower limbs are the common symptoms of Omicron.
So self limiting Fever for a couple of days, a lot of body ache, sore throat, tiredness and occasionally loose bowel motions may be the symptoms of Omicron infection.
The symptoms have evolved because of the mutation that the virus has undergone. Also, the symptoms vary from person to person, depending on their immunity, vaccination status. Symptoms only offer clues and are not sure-shot ways to know about the infection.
Omicron has departed from the traditional Covid symptoms as loss of smell and taste and breathing troubles are rarely present in Omicron cases. Scratchy throat and some other common cold and flu-like symptoms have been associated with Omicron. The absence of respiratory problems has made Omicron appear less severe.
So rest at home with an adequate immune boosting diet with or without symptomatic treatment may help to relieve symptoms.
So to avoid COVID-19 or Delta or Omicron infection it is better to get vaccinated against COVID-19 infections along with wearing of masks, social distancing and frequent hand washing.
Competing interests: No competing interests
17 January 2022
M.A. Aleem
Emeritus Professor of Neurology * Visiting Specialist in Neurology ** Consultant Neurologist ***
The Tamilnadu Dr.M.G.R. Medical University * Dhanalakshami Srinivasan Medical College ** ABC Hospital ***
Chennai 600032* Perambalure 621212** Trichy 620018*** Tamilnadu India
@drmaaleem
Sunday, January 16, 2022
#Omicron Symptoms are very mild in #India - M.A.Aleem Neurologist #Trichy #Tamilnadu #India
Omicron Symptoms are very mild
- M.A.Aleem Neurologist #Trichy #Tamilnadu #India
Symptoms of Omicron as “very, very mild” compared with those of the Delta variant.
Unlike in other variants, patients with Omicron infection have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.
The following are the Omicron symptoms:
A.Cough, cold and fever are common symptoms of Covid, be it Omicron or Delta.
Pulmonary alveolar involvement by Delta induces dry cough.
Dry cough is common in Delta infection
Tracheo bronchitis of Omicron causes secretions not seen with Delta. So Sore throat with mild secretions is with Omicron infection.
Often patients do not expectorate secretions but may just swallow.
B.Sore throat is a very common symptom of Omicron, not so much of Delta, but it may happen sometimes.
C.Headache, tiredness, body pain are apparently more prominent symptoms of Omicron infection than Delta.
D. Breathing problem is a very rare symptom of Omicron, very common of Delta,
E.In general upper respiratory symptoms (cold, cough, sore throat) plus prominent gastrointestinal symptoms (nausea, vomiting, diarrhoea) along with fever , tiredness muscle pain in the lower back and lower limbs are the common symptoms of Omicron infection.
So In this days, Fever for a couple of days, a lot of body ache, sore throat, tiredness occasionally loose motion may be the symptoms of Omicron infection.
The symptoms have evolved because of the mutation that the virus has undergone. Also, the symptoms vary from person to person, depending on their immunity, vaccination status. Symptoms only offer clues and are not sure-shot ways to know about the infection
Omicron has recorded a departure from the traditional Covid symptoms as loss of smell and taste and breathing troubles are rarely present in Omicron cases. Scratchy throat and some other common cold and flu-like symptoms have been associated with Omicron. The absence of respiratory problems has made Omicron appear less severe.
So without panic, with
rest at home with adequate immune booster diet along with or without symptomatic treatment may help to relieve your symptoms
So to avoid COVID-19 or Delta or Omicron infection it is better to get vaccinated against COVID-19 infections along with wearing of mask, social distancing and frequent hand washing
Saturday, January 15, 2022
Friday, January 14, 2022
New drugs for COVID-19 infection- M.A.Aleem BMJ 2022;376:o61
BMJ British Medical Journal
News
Covid-19: We have good treatments for omicron, but questions remain, say doctors
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o61 (Published 11 January 2022)
Cite this as: BMJ 2022;376:o61
Rapid response
Re: Covid-19: We have good treatments for omicron, but questions remain, say doctors
Dear Editor
New drugs for COVID-19 infection
Today, 14.01.2022, the World Health Organisation has recommended two new drugs for COVID-19 infection.
One is baricitinib for severe or critical COVID-19 infection and the other is Sotrovimab for mild or moderate COVID-19 infection.
Newly recommended baricitinib is a Janus kinase (JAk) inhibitor, and this agent along with the corticosteroids can suppress the overstimulated immune system in severe or critical COVID-19 infection. This is This is an oral drug used in the treatment of rheumatoid arthritis.
Sotrovimab is a monoclonal antibody which is recommended for COVID-19 infection in older, unvaccinated, immunocompromised patients with underlying diabetes, hypertension and obesity at high risk of hospitalization.
This agent is an alternative to casirivimab-imdevimab, a monoclonal antibody cocktail in mild to moderate COVID-19 infection.
These two newly recommended drugs - baricitinib and sotrovimab - have been invited for WHO Prequalification, which assesses the quality, efficacy and safety of priority health products to increase access in lower income countries.
Competing interests: No competing interests
14 January 2022
M.A. Aleem
Emeritus Professor of Neurology * Visiting Specialist in Neurology ** Consultant Neurologist ***
The Tamilnadu Dr.M.G.R. Medical University * Dhanalakshami Srinivasan Medical College ** ABC Hospital ***
Chennai 600032* Perambalure 621212** Trichy 620018*** Tamilnadu India
@drmaaleem
Thursday, January 13, 2022
Wednesday, January 12, 2022
Tuesday, January 11, 2022
M.A.Aleem Neurologist Emeritus Professor of Neurology ,Former Vice Principal HOD and Professor of Neurology KAPV Government Medical college #Trichy #Tamilnadu #India has Given an Invited Lecture on "Beware of #Omicron" atAnna Science Centre and Planetarium after inaugurating the Meet the Medical Expert by the students Program on 11.01.2022 organised by the Project Director Ahilan
Monday, January 10, 2022
#VaccinationDrive#COVID19Vaccination COVID-19 Vaccination in #India- M.A.Aleem BMJ 2022;376:o6
BMJ British Medical Journal
Editor's Choice
Prioritising health to save lives
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o6 (Published 06 January 2022)
Cite this as: BMJ 2022;376:o6
Rapid response
Re: Prioritising health to save lives
Dear Editor
COVID-19 Vaccination in India
In the fight against COVID-19, India has crossed a historic 150 COVID-19 vaccination mark today (07.01.2022) with the leadership of our Prime Minister Narendra Modi.
In the COVID-19 vaccination program for children aged 15 to 18 years of age, within five days (03.01.2022 to 07.01.2023) of its initiation, about 1.5 crore children were vaccinated against COVID-19 in India.
As of today 07.01.2022, over 90% of the Indian adult population has already received the first dose of vaccine against COVID-19.
"It is a huge number in terms of statistics. It is not lesser than a surprise for most of the big countries of the world. But it is a symbol of the capability of the 130 crore citizens of India. It is a symbol of self- confidence and self-reliance," our Prime Minister Narendra Modi said today.
The Government of India has also decided that a precautionary dose of vaccine will be started for healthcare and frontline workers starting January 10, 2022. Citizens above 60 years facing co-morbidities will have the option of taking a precautionary dose on the advice of their doctor.
Senior citizens will have to show a medical certificate that shows they have specified co-morbidities to be eligible for a precautionary dose. They will have to get a certificate from a registered medical practitioner that can be scanned and uploaded on the CoWIN portal or produced at a vaccination centre.
The gap between the second dose of COVID-19 vaccine and the third, which is being called a "precaution dose", is likely to be 9 to 12 months.
Official data show there are at least 137.5 million people above the age of 60 years who could be eligible for the precaution dose.
One could give an additional dose of the same vaccine but the results aren't as good as when the jabs are mixed.
With the emergence of the highly contagious Omicron variant of coronavirus, many fully vaccinated people are at risk of getting infected again.
A booster is given to people with weak immunity, especially the elderly, and those with low antibody levels. The idea is to increase the level of protection by increasing the antibodies by taking the exact same amount of another shot of the Covid vaccine.
Competing interests: No competing interests
07 January 2022
M.A. Aleem
Emeritus Professor of Neurology * Visiting Specialist in Neurology ** Consultant Neurologist ***
The Tamilnadu Dr.M.G.R. Medical University * Dhanalakshami Srinivasan Medical College ** ABC Hospital ***
Chennai 600032* Perambalure 621212** Trichy 620018*** Tamilnadu India
@drmaaleem
Sunday, January 9, 2022
#Booster #COVID19Vaccination dose as "#PrecautionaryDose Inevitable"for #Elderly with comorbidities & for Frontline workers says M.A.Aleem #Tamilnadu #India in #Trichy The Hindu @the_hindu Readers Mail Column 10.01.22Readers Mail https://www.thehindu.com/todays-paper/tp-national/tp-tamilnadu/readers- mail/article38212490.ece
